03 / BioPharma

ZeroChain — Ark2 Labs’ Biodiversity Intelligence Platform.

Its high-integrity ledger preserves the evidentiary lifecycle of biological assets, linking collection events, environmental context, sequencing workflows, analytical outputs, and commercial rights into a verifiable chain. This infrastructure enables Ark2 Labs to operate a governed, auditable, and commercially ready discovery platform capable of supporting research access, evaluation, and licensing with institutional confidence.

DNA helix with teal data filaments

Ark2 Labs on ZeroChain: Biodiversity Intelligence built from governed scientific workflows.

Ark2 Labs operates a Biodiversity Intelligence Platform that transforms marine biodiversity into structured, contextualised scientific and commercial assets. Through targeted discovery, genomics, transcriptomics, environmental sensing, and governed asset creation, Ark2 produces Contextual Biodiversity Profiles, BGC evaluation packages, and enterprise-grade biological datasets capable of supporting research access, evaluation, and licensing.

ZeroChain integrates beneath this workflow to maintain evidentiary continuity, but the scientific, analytical, and commercial value originates from Ark2’s discovery architecture.

Discovery

Marine Biodiversity Intelligence

Ark2 Labs conducts targeted marine biodiscovery across biologically rich regions. Each collection event generates biological, environmental, transcriptomic, and provenance information that becomes part of a governed Contextual Biodiversity Profile.

Provenance

Immutable evidentiary lineage

ZeroChain anchors collection identifiers, environmental context, custody events, sequencing workflows, analytical processing, rights status, and licensing history. This supports scientific review, governance reporting, and commercial diligence without exposing sensitive underlying data.

Licensing

Governed commercial pathways

Selected Biosynthetic Gene Clusters (BGCs) may progress into controlled evaluation, option arrangements, or licensing agreements. ZeroChain records licence events, rights modifications, and benefit-sharing obligations as part of the asset’s evidentiary lifecycle.

AI Trust

Verifiable models

ZeroChain supports selective disclosure through Tessera privacy enclaves and Zero-Knowledge Proofs, enabling partners to verify model inputs, outputs, and lineage without accessing proprietary biological information.

Privacy

Confidential Integrity

Sensitive scientific and commercial records remain protected while authorised reviewers gain verifiable assurance over provenance, custody, and rights-management events.

Sovereignty

Source-nation aligned governance

Ark2 Labs incorporates Access and Benefit Sharing frameworks and allocates 15% of net revenue to host governments, conservation programmes, and participating communities. ZeroChain preserves the associated rights and obligations throughout the asset lifecycle.

Provenance chain

A Complete Evidentiary Chain for Biological Assets

From field collection → environmental context → sequencing → transcriptomics → cDNA → BGC assessment → rights management → licensing. Every stage is hash-linked, reviewable, and governed.